Sichuan Haisco Pharmaceutical Group Co., Ltd clinical trials

A subsidiary of Haisco Pharmaceutical Group Co., Ltd.

The registry lists 30 studies whose lead sponsor is Sichuan Haisco Pharmaceutical Group Co., Ltd. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Feb 22, 2023.

Studies

Recruiting first, then most recently updated. Showing 30 of 30. All Haisco Pharmaceutical Group Co., Ltd. studies →

• Safety, Tolerability and Pharmacokinetics of HSK21542 in Healthy VolunteersCompletedNCT04213196Phase 1

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• HSK7653 Metformin Add-on Study in Patients With Type 2 Diabetes MellitusCompletedNCT04564872Phase 3

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• Mass Balance and Biotransformation of [14C]HSK7653 in HumanCompletedNCT04540016Phase 1

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• HSK7653 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseCompletedNCT04556851Phase 3

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• A Study Evaluating the Mass Balance of Micro-dose[14C]HSK3486 Emulsion Injection in Healthy AdultsWithdrawnNCT03751969Phase 1

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• A Study Evaluating the Efficacy and Safety of HSK3486 for SedationCompletedNCT04147416Phase 2

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• Safety, Tolerability, and Pharmacokinetics of HSK21542 in Healthy VolunteersCompletedNCT04110886Phase 1

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• Safety, Tolerability and Pharmacokinetics of FTP-198 in Healthy Australian VolunteersCompletedNCT04526496Phase 1

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• A Study Evaluating Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of HSK3486 Single Bolus Dose Followed With a 30 Minute Constant Infusion in Healthy Male SubjectsCompletedNCT04029766Phase 1

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Impairment Renal FunctionsCompletedNCT04142970Phase 1

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Voriconazole TabletsCompletedNCT04145583Phase 1

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Hepatic ImpairmentCompletedNCT04145596Phase 1

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• A Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion in Subjects Undergoing Fiberoptic BronchoscopyCompletedNCT04111159Phase 3

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Healthy Elderly SubjectsCompletedNCT04197661Phase 1

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• A Clinical Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion in Elective Surgery PatientsCompletedNCT04048811Phase 2

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• Efficacy and Safety of Polyene Phosphatidylcholine in Treatment of Patients With Acute Drug-induced Liver InjuryCompletedNCT04595916Phase 4

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• A Study on the Bioequivalence of Perindopril Tert-butylamine Tablets Taken on an Empty Stomach in Healthy SubjectsCompletedNCT04556058Phase 1

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• A Study on the Bioequivalence of Perindopril Tert-butylamine Tablets Taken on After Meals in Healthy SubjectsCompletedNCT04556110Phase 1

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• A Study Evaluating Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Single IV Dose of HSK3486 Injectable Emulsion in Healthy Subjects.CompletedNCT03773835Phase 1

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• A Study Evaluating the Safety and Pharmacokinetics/Pharmacodynamics of HSK3486CompletedNCT03745625Phase 1

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• A Study Evaluating the Mass Balance of [14C]HSK3486 Emulsion Injection in Healthy Adults.CompletedNCT03751956Phase 1

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• A Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion for the Induction of General Anesthesia in Elective Surgery SubjectsCompletedNCT03808844Phase 3

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Rifampin CapsulesCompletedNCT03758469Phase 1

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• A Study Evaluating Safety, Pharmacodynamics and Pharmacokinetics of HSK3486 and Etomidate for Induction of Anesthesia in Healthy Male SubjectsCompletedNCT04054063Phase 1

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• Evaluating the Safety, Pharmacodynamics and Pharmacokinetics of HSK3486 in Healthy Female Subjects.CompletedNCT04037657Phase 1

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• A Study Evaluating the Safety, Pharmacodynamics and Pharmacokinetics of HSK3486 in Healthy Subjects.CompletedNCT04033939Phase 1

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• A Phase III Study Evaluating The Efficacy and Safety of HSK3486 for Sedation or AnesthesiaCompletedNCT03674008Phase 3

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• A Study Evaluating Tolerability, Efficacy, and Safety of HSK3486 Injectable Emulsion in PatientsCompletedNCT03773042Phase 2

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• A Study Evaluating the Efficacy and Safety of HSK3486CompletedNCT03709056Phase 2

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd

• A Phase IIa Study Investigating the Tolerance, Efficacy and Safety of HSK3486CompletedNCT03698617Phase 2

  Sponsor listed in the registry: Sichuan Haisco Pharmaceutical Group Co., Ltd